Injectable biodegradable polymer compositions for soft tissue repair and augmentation
Methods for soft tissue repair and/or augmentation using injectable, biodegradable polymers are described herein. In one embodiment, the polymer compositions are liquid or pastes at room temperature. In a preferred embodiment, the polymer composition contains liquid or pasty hydroxy fatty acid-based copolyesters, polyester-anhydrides, or combinations thereof. The viscosity of the polymers increases upon contact with bodily fluid to form a solid or semisolid implant suitable for soft tissue repair and/or augmentation. In another embodiment, the polymer composition contains particles of a polymer stereocomplex. One or more active agents may be incorporated into the polymer compositions. Suitable classes of active agents include local anesthetics, anti-inflammatory agents, antibiotics, analgesics, growth factors and agents that induce and/or enhance growth of tissue within the filled cavity or control the growth of a certain type of tissue, and combinations thereof. The polymer compositions may also contain one or more additives or excipients that modify the physical and/or mechanical properties of the polymer. The polymer compositions are typically administered by injection. The injectable polymers can be used for a variety of soft tissue repair and augmentation procedures.
1. A method of repairing or augmenting soft tissue, the method comprising administering to a patient at a site for repair or augmentation an effective amount of an injectable biocompatible, biodegradable polymer composition, wherein said composition is stable for a period of 6 to 24 months in the soft tissue, said composition comprising
(a) a copolymer comprising:
(i) a first monomer which is castor oil, and
(ii) a second monomer derived from a polyfunctional organic molecule, wherein the polymer is a liquid or paste at room temperature, and wherein the polymer increases its viscosity when exposed to physiological fluids, wherein said polyfunctional organic molecule is selected from the group consisting of lactic acid, a lactone and sebacic acid, and wherein a ratio of lactic acid to castor oil is no greater than 60:40; or
(b) particles comprising a polymer stereocomplex, wherein the stereocomplex comprises block copolymers comprising stereoregular segments of D-lactic acid and L-lactic acid, wherein the D-Lactic acid block and the L-lactic acid block comprises at least 10 monomer units and wherein the copolymer is selected from the group consisting of poly(D-lactide-co-castor oil), poly(L-lactide-co-castor oil), poly(DL-lactide-co-castor oil), poly(caprolactone-castor oil), (PCLCO), poly(lactic acid-castor oil) (PLACO), and combinations thereof.
2. The method of claim 1 , wherein the tissue to be repaired or augmented is skin.
3. The method of claim 1 , wherein the polymer is injected into facial soft tissue to provide facial contouring.
4. The method of claim 1 , wherein the polymer is used to repair or augment a defect in facial tissue, the defect selected from the group consisting of scars, depressions, irregularities, asymmetry in facial hemiatrophy, second bronchial arch syndrome, facial lipodystrophy, wrinkles and facial eminences.
5. The method of claim 1 , wherein the tissue to be repaired or augmented is the sphincter muscle.
6. The method of claim 1 , wherein the tissue to be repaired or augmented is the urinary bladder.
7. The method of claim 6 wherein polymer is administered to treat urinary incontinence.
8. The method of claim 6 wherein the polymer is administered to treat vesicoureteral reflux.
9. The method of claim 1 , wherein the polymer is administered as a treatment for lip augmentation, filling or shaping.
10. The method of claim 1 , wherein the polymer is administered for cheek enhancement.
11. The method of claim 1 , wherein the polymer is administered as a permanent implant filler for breast augmentation.
12. The method of claim 1 , wherein the polymer is administered as a permanent filler or tissue expander for the creation of extra tissue for surgical flaps.
13. The method of claim 1 , wherein said composition does not feature an additional active ingredient.